Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.26 USD | +0.34% | -0.03% | -10.13% |
28/02 | Inhibrx Shares Fall After Q4 Net Loss Widens | MT |
28/02 | Earnings Flash (INBX) INHIBRX Reports Q4 Revenue $1.6M | MT |
Evolution of the average Target Price on Inhibrx, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Inhibrx, Inc.
JMP Securities | |
Credit Suisse | |
Evercore ISI | |
SMBC Nikko |
EPS Revisions
- Stock Market
- Equities
- INBX Stock
- Consensus Inhibrx, Inc.